Linda D'Andrea, MSN RN PPCNP-BC CPHON®Pediatric Nurse Practitioner

Linda D’Andrea is a pediatric nurse practitioner with the neuroblastoma service at Memorial Sloan Kettering Cancer Center (MSK). She is a graduate and Hillman Scholar of the University of Pennsylvania School of Nursing where she received her BSN in 1996 and her MSN in 1999 from their Pediatric Acute/Chronic Advanced Practice Nurse Program. She began her nursing career in 1996 at NY Presbyterian Hospital-Weill Cornell Medical Center in the PICU, where she served as staff nurse, senior staff nurse, assistance nurse manager, and clinical nurse specialist for all pediatrics programs, earning the institution’s Excellence in Nursing Award. Since joining MSK in 2004, Linda has been active in many service-, departmental-, and hospital-wide initiatives. She co-chairs the Pediatric Education Committee, is chair of the Advanced Practice Provider (APP) Professional Development Council, and was a member of MSK’s inaugural NP Council, for which she served as co-chair and chair. Linda also is the course coordinator for the Advanced Concepts in Pediatric Oncology CME program, co-coordinator of MSK's pediatric APP fellowship, and the lead planning committee member for Radiologic Interpretation in the Oncology Patient for Advanced Practice Providers CME program. In addition to her work at MSK, Linda was the clinical coordinator for the Hillman Scholars Program at UPenn from 2000 - 2014 and the Director of the Hillman Alumni Nursing Network from 2000 – 2017. She was recognized for her contributions to the program in 2017, with the School of Nursing’s Alumni Spirit Award. She has also written several chapters on neuroblastoma, is a content reviewer for the Association of Pediatric Hematology Oncology Nurses, worked extensively with the Ronald McDonald House, coordinating and provides pediatric oncology educational programming for staff, volunteers, and donors, and lectures at Columbia University in the Pediatric Oncology Nurse Practitioner Program. 
Administration and Management of Anti-GD2 Immunotherapy for High Risk Neuroblastoma in the Outpatient Setting (200)
Memorial Sloan Kettering Cancer Center
Montvale, New Jersey